Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...
In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...
Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.
Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.
BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) and an ejection fraction (EF) that has improved over time. This study ...
More potent DAPT strategies and oral anticoagulation were tied to worse outcomes and should be avoided, researchers say.
ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...
US and European guidelines for atrial fibrillation differ in subtle but important ways that are swaying treatment decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback